Steffen P. Häseli

Steffen P. Häseli

Auto-generated profile, based on publicly available information

Steffen P. Häseli

Department of Radiology, Charité University Hospital Berlin, Berlin, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TGTilman Grune
Tilman Grune
COChristiane Ott
Christiane Ott
SHSteffen Häseli
Steffen Häseli
AHAnnika Höhn
Annika Höhn
TJTobias Jung
Tobias Jung
Measurement and quantification of cardiomyocyte or cardiac contractions as important (patho) physiologic parameters require highly specialized and expensive setups of fully integrated hard- and software that may be very difficult to use and may also depend on highly sophisticated methods of further data evaluation. With MYOCYTER (MC) we present a complete and highly customizable open-source macro for ImageJ, enabling fast, reliable user-friendly large scale analysis extracting an extensive amount of parameters from (even multiple) video recorded contracting cells or whole hearts, gained from a very competitive experimental setup. The extracted parameters enable extensive further (statistical) analysis to identify and quantify the effects of pathologic changes or drugs. Using videos following known mathematical functions, we were able to demonstrate the accuracy of MYOCYTER’s data extraction, also successfully applied the software to both cellular and animal models, introducing innovations like dynamic thresholding, automatic multi-cell recognition, “masked” evaluation and change of applied parameters even after evaluation.

27 September 2024 in Circulation Research
Verified
Journal Article
Closed access
SSStefano Strocchi
Stefano Strocchi
LLLuo Liu
Luo Liu
RWRongling Wang
Rongling Wang
SHSteffen P. Häseli
Steffen P. Häseli
FCFederico Capone
Federico Capone
GSGabriele G. Schiattarella
Gabriele G. Schiattarella

23 February 2026 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
FCFederico Capone
Federico Capone
SHSteffen P. Häseli
Steffen P. Häseli
LLLuo Liu
Luo Liu
SSStefano Strocchi
Stefano Strocchi
CLClaudia Langenberg
Claudia Langenberg
GSGabriele G. Schiattarella
Gabriele G. Schiattarella

15 April 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
SHSteffen Häseli
Steffen Häseli
SDStefanie Deubel
Stefanie Deubel
TJTobias Jung
Tobias Jung
TGTilman Grune
Tilman Grune
COChristiane Ott
Christiane Ott
Globally, cardiovascular diseases are the leading cause of death in the aging population. While the clinical pathology of the aging heart is thoroughly characterized, underlying molecular mechanisms are still insufficiently clarified. The aim of the present study was to establish an in vitro model system of cardiomyocyte premature senescence, culturing heart muscle cells derived from neonatal C57Bl/6J mice for 21 days. Premature senescence of neonatal cardiac myocytes was induced by prolonged culture time in an oxygen-rich postnatal environment. Age-related changes in cellular function were determined by senescence-associated β-galactosidase activity, increasing presence of cell cycle regulators, such as p16, p53, and p21, accumulation of protein aggregates, and restricted proteolysis in terms of decreasing (macro-)autophagy. Furthermore, the culture system was functionally characterized for alterations in cell morphology and contractility. An increase in cellular size associated with induced expression of atrial natriuretic peptides demonstrated a stress-induced hypertrophic phenotype in neonatal cardiomyocytes. Using the recently developed analytical software tool Myocyter, we were able to show a spatiotemporal constraint in spontaneous contraction behavior during cultivation. Within the present study, the 21-day culture of neonatal cardiomyocytes was defined as a functional model system of premature cardiac senescence to study age-related changes in cardiomyocyte contractility and autophagy.

11 March 2026 in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
Verified
Journal Article
Open access
PDF file
FWFelix Pablo Widmann
Felix Pablo Widmann
SHSteffen P. Häseli
Steffen P. Häseli
JSJakob Schattenfroh
Jakob Schattenfroh
JBJan Bieling
Jan Bieling
NJNoah Jaitner
Noah Jaitner
RRRolf Reiter
Rolf Reiter
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease associated with an increased risk of liver fibrosis, liver cirrhosis, and the development of hepatocellular carcinoma. Magnetic resonance elastography (MRE) has been established for non-invasively grading hepatic fibrosis and is increasingly used for assessing inflammation in research studies. The first pharmaceutical treatment of MASH –Resmetirom – was approved in the United States in March 2024 and received approval in Europe in August 2025. This circumstance will increase the demand for clinical and research MRE examinations. Therefore, this scoping review aims to provide an overview of the current research on the use of MRE in MASH for assessing fibrosis and inflammation. A structured literature search was carried out within the MEDLINE and Embase + Embase Classic databases. A total of 11 studies within the last five years were included based on predefined criteria, such as prospective study design, histopathological validation as reference standard or comparisons with other non-invasive procedures. The included studies encompassed diverse populations, methods, and outcome criteria. MRE demonstrated excellent diagnostic performance for liver fibrosis (AUC up to 0.97), outperforming many other non-invasive fibrosis tests. Additionally, preliminary studies suggest good performance for hepatic inflammation (AUC up to 0.83). Multiparametric approaches that combine MRE with other quantitative MRI-based methods, such as proton density fat fraction (PDFF) and corrected T1 (cT1), could further improve diagnostic performance in MASH. These findings show that MRE is a reliable tool for non-invasively assessing hepatic fibrosis in MASH and shows promise to assess inflammation in the future.

27 May 2026 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Open access
SHSteffen P. Häseli
Steffen P. Häseli
JSJakob Schattenfroh
Jakob Schattenfroh
TMTom Meyer
Tom Meyer
PSPaul Spiesecke
Paul Spiesecke
TPTobias Puengel
Tobias Puengel
RRRolf Reiter
Rolf Reiter
Hepatic iron overload, as observed in hemochromatosis, is a relevant contributor to chronic liver disease and can promote liver fibrosis, which plays a key role in hepatic morbidity and mortality. We herein report the case of a lean 36-year-old Caucasian male with chronic hepatopathy related to severe iron overload. In this case, imaging-based staging of liver-fibrosis was not possible using multi-driver, multifrequency magnetic resonance (MR)-based tomoelastography (MRE). Resulting images revealed anatomically precise cut-outs of the liver and uniquely demonstrated an unprecedented limitation of this high-precision protocol. While liver biopsy revealed only mild hepatitis and early perisinusoidal fibrosis, reliable MRE-based measurement of liver stiffness was not possible. Only additional use of ultrasound-based elastography (USE) confirmed slight stiffening of the liver, ruling out severe cirrhosis. In conclusion, this case study underlines the importance of diagnostic time-harmonic elastography using different modalities. Based on our experience, we make suggestions for more reliable prognostic evaluation of liver fibrosis in this poorly reviewed clinical scenario.